BIOMAT Database Logo BIOMAT Database Logo

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. 1987

A Zeevi, and R Duquesnoy, and G Eiras, and H Rabinowich, and S Todo, and L Makowka, and T E Starzl
Department of Immunopathology, University of Pittsburgh, PA 15213-3417.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

A Zeevi, and R Duquesnoy, and G Eiras, and H Rabinowich, and S Todo, and L Makowka, and T E Starzl
Immunosuppressive effect of bactobolamine on in vitro lymphocyte alloactivation: synergism with cyclosporine.
November 2000, Transplantation proceedings,
A Zeevi, and R Duquesnoy, and G Eiras, and H Rabinowich, and S Todo, and L Makowka, and T E Starzl
Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro.
June 1989, Transplantation proceedings,
A Zeevi, and R Duquesnoy, and G Eiras, and H Rabinowich, and S Todo, and L Makowka, and T E Starzl
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.
September 1987, The Journal of antibiotics,
A Zeevi, and R Duquesnoy, and G Eiras, and H Rabinowich, and S Todo, and L Makowka, and T E Starzl
2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506).
January 1995, Archivum immunologiae et therapiae experimentalis,
A Zeevi, and R Duquesnoy, and G Eiras, and H Rabinowich, and S Todo, and L Makowka, and T E Starzl
Effect of FK-506 on human mixed lymphocyte reaction in vitro.
October 1987, Transplantation proceedings,
A Zeevi, and R Duquesnoy, and G Eiras, and H Rabinowich, and S Todo, and L Makowka, and T E Starzl
Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3-stimulated human lymphocyte proliferation in vitro.
December 1991, Transplantation proceedings,
A Zeevi, and R Duquesnoy, and G Eiras, and H Rabinowich, and S Todo, and L Makowka, and T E Starzl
Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine.
February 1995, Transplantation proceedings,
A Zeevi, and R Duquesnoy, and G Eiras, and H Rabinowich, and S Todo, and L Makowka, and T E Starzl
Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation.
April 1992, Transplantation proceedings,
A Zeevi, and R Duquesnoy, and G Eiras, and H Rabinowich, and S Todo, and L Makowka, and T E Starzl
FK 506 versus cyclosporine.
February 1993, Transplantation proceedings,
A Zeevi, and R Duquesnoy, and G Eiras, and H Rabinowich, and S Todo, and L Makowka, and T E Starzl
Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine.
December 1991, Transplantation proceedings,
Copied contents to your clipboard!